RECURSION PHARMACEUTICALS

Serial Number 87356060
Registration 5310305
702

Registration Progress

Application Filed
Mar 2, 2017
Under Examination
Approved for Publication
Aug 1, 2017
Published for Opposition
Aug 1, 2017
Registered
Oct 17, 2017

Trademark Image

RECURSION PHARMACEUTICALS

Basic Information

Serial Number
87356060
Registration Number
5310305
Filing Date
March 2, 2017
Registration Date
October 17, 2017
Published for Opposition
August 1, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Apr 15, 2024
Registration
Registered
Classes
042

Rights Holder

Recursion Pharmaceuticals, Inc.

03
Address
41 South Rio Grande Street
Salt Lake City, UT 84101

Ownership History

Recursion Pharmaceuticals, Inc.

Original Applicant
03
Salt Lake City, UT

Recursion Pharmaceuticals, Inc.

Owner at Publication
03
Salt Lake City, UT

Recursion Pharmaceuticals, Inc.

Original Registrant
03
Salt Lake City, UT

Legal Representation

Attorney
David P. Johnson

USPTO Deadlines

Next Deadline
620 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20171017)
Due Date
October 17, 2027
Grace Period Ends
April 17, 2028

Application History

25 events
Date Code Type Description Documents
Apr 15, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Apr 15, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 15, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 17, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 17, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 16, 2021 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Mar 12, 2021 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Feb 26, 2021 PRAM O POST REGISTRATION ACTION MAILED - SEC. 7 Loading...
Feb 16, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 21, 2021 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Oct 17, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 1, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 1, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 12, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 7, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 7, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 7, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 27, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
May 27, 2017 GPRA F PRIORITY ACTION E-MAILED Loading...
May 27, 2017 CPRA R PRIORITY ACTION WRITTEN Loading...
May 25, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services
First Use Anywhere: Nov 16, 2013
First Use in Commerce: Nov 16, 2013

Additional Information

Other
In the statement, line 1, "Utah" should be deleted, and "Delaware" should be inserted.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"